scholarly journals Survival of HIV-Infected Injection Drug Users (IDUs) in the Highly Active Antiretroviral Therapy Era, Relative to Sex- and Age-Specific Survival of HIV-Uninfected IDUs

2007 ◽  
Vol 45 (3) ◽  
pp. 370-376 ◽  
Author(s):  
R. Muga ◽  
K. Langohr ◽  
J. Tor ◽  
A. Sanvisens ◽  
I. Serra ◽  
...  
Keyword(s):  
Antiretroviral Therapy ◽  
Highly Active Antiretroviral Therapy ◽  
Injection Drug Users ◽  
Drug Users ◽  
Injection Drug ◽  
Highly Active

Ongoing drug use and outcomes from highly active antiretroviral therapy among injection drug users in a Canadian setting

2010 ◽  
Vol 15 (5) ◽  
pp. 789-796 ◽  
Author(s):  
Andrea Krusi ◽  
M-J Milloy ◽  
Thomas Kerr ◽  
Ruth Zhang ◽  
Silvia Guillemi ◽  
...  
Keyword(s):  
Antiretroviral Therapy ◽  
Drug Use ◽  
Highly Active Antiretroviral Therapy ◽  
Injection Drug Users ◽  
Drug Users ◽  
Injection Drug ◽  
Highly Active ◽  
Canadian Setting

Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users

AIDS ◽  
2001 ◽  
Vol 15 (13) ◽  
pp. 1707-1715 ◽  
Author(s):  
David D. Celentano ◽  
Noya Galai ◽  
Ajay K. Sethi ◽  
Nina G. Shah ◽  
Steffanie A. Strathdee ◽  
...  
Keyword(s):  
Antiretroviral Therapy ◽  
Highly Active Antiretroviral Therapy ◽  
Injection Drug Users ◽  
Drug Users ◽  
Injection Drug ◽  
Highly Active

Sexual and drug risk-related behaviours after initiating highly active antiretroviral therapy among injection drug users

AIDS ◽  
2001 ◽  
Vol 15 (17) ◽  
pp. 2311-2316 ◽  
Author(s):  
David Vlahov ◽  
Mahboobeh Safaien ◽  
Shenghan Lai ◽  
Steffanie A. Strathdee ◽  
Lisette Johnson ◽  
...  
Keyword(s):  
Antiretroviral Therapy ◽  
Highly Active Antiretroviral Therapy ◽  
Injection Drug Users ◽  
Drug Users ◽  
Injection Drug ◽  
Highly Active ◽  
Drug Risk

scholarly journals Access to highly active antiretroviral therapy for injection drug users: adherence, resistance, and death

2006 ◽  
Vol 22 (4) ◽  
pp. 705-718 ◽  
Author(s):  
David Vlahov ◽  
David D. Celentano
Keyword(s):  
Antiretroviral Therapy ◽  
Highly Active Antiretroviral Therapy ◽  
Injection Drug Users ◽  
Drug Users ◽  
Hiv Treatment ◽  
Injection Drug ◽  
Hiv Viral Load ◽  
High Risk Behaviors ◽  
Highly Active ◽  
Abuse Treatment

Injection drug users (IDUs) continue to comprise a major risk group for HIV infection throughout the world and represent the focal population for HIV epidemics in Asia and Eastern Europe/Russia. HIV prevention programs have ranged from HIV testing and counseling, education, behavioral and network interventions, drug abuse treatment, bleach disinfection of needles, needle exchange and expanded syringe access, as well as reducing transition to injection and primary substance abuse prevention. With the advent of highly active antiretroviral therapy (HAART) in 1996, dramatic clinical improvements have been seen. In addition, the treatment's impact on reducing HIV viral load (and therefore transmission by all routes) provides a stronger rationale for an expansion of the focus on prevention to emphasize early identification and treatment of HIV infected individuals. However, treatment of IDUs has many challenges including adherence, resistance and relapse to high risk behaviors, all of which impact issues of access and ultimately effectiveness of potent antiretroviral treatment. A major current challenge in addressing the HIV epidemic revolves around an appropriate approach to HIV treatment for IDUs.

Sign in / Sign up

Export Citation Format

Share Document